Managed Account Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Managed Account Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$40M	Sell	265,360 -16,646	-6%	-$2.38M	0.03%	483
2015 Q1	$38.1M	Sell	282,006 -4,804	-2%	-$595K	0.03%	483
2014 Q4	$34.6M	Sell	286,810 -5,780	-2%	-$665K	0.03%	490
2014 Q3	$33.2M	Sell	292,590 -3,840	-1%	-$455K	0.04%	484
2014 Q2	$35.5M	Buy	296,430 +764	+0.3%	+$93.3K	0.04%	449
2014 Q1	$37.9M	Sell	295,666 -1,339	-0.5%	-$172K	0.05%	408
2013 Q4	$36.7M	Buy	297,005 +5,925	+2%	+$722K	0.05%	411
2013 Q3	$34.2M	Buy	291,080 +4,469	+2%	+$527K	0.05%	403
2013 Q2	$32.2M	Buy	+286,611	New	+$33.6M	0.05%	401

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Managed Account Advisors's BIO Position: Q2 2015 in Review

Managed Account Advisors reduced its Bio-Rad Laboratories Class A (BIO) stake by 5.9% in Q2 2015, selling an estimated $2.38M and leaving 265,360 shares worth $40M. The position accounts for 0.03% of the portfolio, ranked #483.

Managed Account Advisors first reported a position in BIO in Q2 2013 and has held it in 9 quarters since. 225 funds tracked by Wall St. Rank hold BIO as of Q2 2015.

Managed Account Advisors held 265,360 shares of Bio-Rad Laboratories Class A worth $40M as of Q2 2015.
Managed Account Advisors sold 16,646 Bio-Rad Laboratories Class A shares in Q2 2015, an estimated $2.38M.
Bio-Rad Laboratories Class A made up 0.03% of Managed Account Advisors's portfolio in Q2 2015, its #483 holding.
Managed Account Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 9 quarters since.
225 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.